Oxidative stress and pulmonary fibrosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 7, 2013, Pages 1028-1040

  Cheresh, Paul ^a   Kim, Seok Jo ^a   Tulasiram, Sandhya ^a   Kamp, David W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Epithelium; Mitochondria; NADPH oxidase; Reactive oxygen species

Indexed keywords

8 HYDROXYGUANINE; ACO2 PROTEIN; MITOCHONDRIAL DNA; OGG1 PROTEIN; PROTEIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOXIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; DNA DAMAGE; DNA REPAIR; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; HUMAN; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MITOCHONDRION; MOLECULAR MECHANICS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG EFFECTS; GENETICS; METABOLISM;

ANIMALS; APOPTOSIS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PULMONARY FIBROSIS;

EID: 84877030807     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.11.021     Document Type: Review

References (170)

1. Faner R., Rojas M., Macnee W., Agusti A. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012, 186:306-313.
2. Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. 2003, 167:1600-1619.
3. Jones D.P. Extracellular redox state: refining the definition of oxidative stress in aging. Rejuvenation Res. 2006, 9:169-181.
4. Sanchez-Valle V., Chavez-Tapia N.C., Uribe M., Mendez-Sanchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr. Med. Chem. 2012, 19:4850-4860.
5. Friedrichs K., Baldus S., Klinke A. Fibrosis in atrial fibrillation - role of reactive species and MPO. Front. Physiol. 2012, 3:214.
6. Gabrielli A., Svegliati S., Moroncini G., Amico D. New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol. J. 2012, 6:87-95.
7. Kliment C.R., Oury T.D. Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis. Free Radic. Biol. Med. 2010, 49:707-717.
8. Winterbourn C.C. Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 2008, 4:278-286.
9. Kamp D.W., Graceffa P., Pryor W.A., Weitzman S.A. The role of free radicals in asbestos-induced diseases. Free Radic. Biol. Med. 1992, 12:293-315.
10. Turci F., Tomatis M., Lesci I.G., Roveri N., Fubini B. The iron-related molecular toxicity mechanism of synthetic asbestos nanofibres: a model study for high-aspect-ratio nanoparticles. Chemistry 2011, 17:350-358.
11. O'Brien P.J. Radical formation during the peroxidase catalyzed metabolism of carcinogens and xenobiotics: the reactivity of these radicals with GSH, DNA, and unsaturated lipid. Free Radic. Biol. Med. 1988, 4:169-183.
12. Liu R.M., Gaston Pravia K.A. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic. Biol. Med. 2010, 48:1-15.
13. Liu R.M., Vayalil P.K., Ballinger C., Dickinson D.A., Huang W.T., Wang S., Kavanagh T.J., Matthews Q.L., Postlethwait E.M. Transforming growth factor beta suppresses glutamate-cysteine ligase gene expression and induces oxidative stress in a lung fibrosis model. Free Radic. Biol. Med. 2012, 53:554-563.
14. Liu G., Cheresh P., Kamp D.W. Molecular basis of asbestos-induced lung disease. Annu. Rev. Pathol.Mech. Des. 2013, 8:161-187.
15. Galluzzi L., Kepp O., Trojel-Hansen C., Kroemer G. Non-apoptotic functions of apoptosis-regulatory proteins. EMBO Rep. 2012, 13:322-330.
16. Osborn-Heaford H.L., Ryan A.J., Murthy S., Racila A.M., He C., Sieren J.C., Spitz D.R., Carter A.B. Mitochondrial Rac1 import and electron transfer from cytochrome c is required for pulmonary fibrosis. J. Biol. Chem. 2012, 287:3301-3312.
17. 2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1. J. Biol. Chem. 2010, 285:25062-25073.
18. Murthy S., Adamcakova-Dodd A., Perry S.S., Tephly L.A., Keller R.M., Metwali N., Meyerholz D.K., Wang Y., Glogauer M., Thorne P.S., Carter A.B. Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L846-L855.
19. 2 generation. J. Biol. Chem. 2011, 286:15597-15607.
20. Mossman B.T., Marsh J.P., Sesko A., Hill S., Shatos M.A., Doherty J., Petruska J., Adler K.B., Hemenway D., Mickey R., et al. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am. Rev. Respir. Dis. 1990, 141:1266-1271.
21. Huang S.X., Jaurand M.C., Kamp D.W., Whysner J., Hei T.K. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J. Toxicol. Environ. Health B Crit. Rev. 2011, 14:179-245.
22. Crestani B., Besnard V., Boczkowski J. Signalling pathways from NADPH oxidase-4 to idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2011, 43:1086-1089.
23. Hecker L., Cheng J., Thannickal V.J. Targeting NOX enzymes in pulmonary fibrosis. Cell. Mol. Life Sci. 2012, 69:2365-2371.
24. Hecker L., Vittal R., Jones T., Jagirdar R., Luckhardt T.R., Horowitz J.C., Pennathur S., Martinez F.J., Thannickal V.J. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 2009, 15:1077-1081.
25. Carnesecchi S., Deffert C., Donati Y., Basset O., Hinz B., Preynat-Seauve O., Guichard C., Arbiser J.L., Banfi B., Pache J.C., Barazzone-Argiroffo C., Krause K.H. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid. Redox Signal. 2011, 15:607-619.
26. Waghray M., Cui Z., Horowitz J.C., Subramanian I.M., Martinez F.J., Toews G.B., Thannickal V.J. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J. 2005, 19:854-856.
27. Yang J., Tan Y., Zhao F., Ma Z., Wang Y., Zheng S., Epstein P.N., Yu J., Yin X., Zheng Y., Li X., Miao L., Cai L. Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E132-E144.
28. Manoury B., Nenan S., Leclerc O., Guenon I., Boichot E., Planquois J.M., Bertrand C.P., Lagente V. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir. Res. 2005, 6:11.
29. Aoyama T., Paik Y.H., Watanabe S., Laleu B., Gaggini F., Fioraso-Cartier L., Molango S., Heitz F., Merlot C., Szyndralewiez C., Page P., Brenner D.A. Nicotinamide adenine dinucleotide phosphate oxidase (nox) in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 2012, 56:2316-2327.
30. Jiang J.X., Chen X., Serizawa N., Szyndralewiez C., Page P., Schroder K., Brandes R.P., Devaraj S., Torok N.J. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic. Biol. Med. 2012, 53:289-296.
31. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., Dikalov S., Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 2005, 97:900-907.
32. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M.D., Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:15565-15570.
33. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
34. Cassel S.L., Eisenbarth S.C., Iyer S.S., Sadler J.J., Colegio O.R., Tephly L.A., Carter A.B., Rothman P.B., Flavell R.A., Sutterwala F.S. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9035-9040.
35. Mossman B.T., Lippmann M., Hesterberg T.W., Kelsey K.T., Barchowsky A., Bonner J.C. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J. Toxicol. Environ. Health B Crit. Rev. 2011, 14:76-121.
36. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
37. Cantin A.M., Hubbard R.C., Crystal R.G. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1989, 139:370-372.
38. Giri S.N., Hyde D.M., Schiedt M.J. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters. J. Lab. Clin. Med. 1988, 111:715-724.
39. Hagiwara S.I., Ishii Y., Kitamura S. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am. J. Respir. Crit. Care Med. 2000, 162:225-231.
40. Borok Z., Buhl R., Grimes G.J., Bokser A.D., Hubbard R.C., Holroyd K.J., Roum J.H., Czerski D.B., Cantin A.M., Crystal R.G. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 1991, 338:215-216.
41. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., MacNee W., Thomeer M., Wallaert B., Laurent F., Nicholson A.G., Verbeken E.K., Verschakelen J., Flower C.D., Capron F., Petruzzelli S., De Vuyst P., van den Bosch J.M., Rodriguez-Becerra E., Corvasce G., Lankhorst I., Sardina M., Montanari M. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2005, 353:2229-2242.
42. Hybertson B.M., Gao B., Bose S.K., McCord J.M. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol. Aspects Med. 2011, 32:234-246.
43. Kikuchi N., Ishii Y., Morishima Y., Yageta Y., Haraguchi N., Itoh K., Yamamoto M., Hizawa N. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir. Res. 2010, 11:31.
44. He X., Wang L., Szklarz G., Bi Y., Ma Q. Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway. J. Pharmacol. Exp. Ther. 2012, 342:81-90.
45. Artaud-Macari E., Goven D., Brayer S., Hamimi A., Besnard V., Marchal-Somme J., Ali Z.E., Crestani B., Kerdine-Romer S., Boutten A., Bonay M. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. Antioxid. Redox Signal. 2012, 10.1089/ars2011.4240.
46. Noble P.W., Barkauskas C.E., Jiang D. Pulmonary fibrosis: patterns and perpetrators. J. Clin. Invest. 2012, 122:2756-2762.
47. Anathy V., Roberson E.C., Guala A.S., Godburn K.E., Budd R.C., Janssen-Heininger Y.M. Redox-based regulation of apoptosis: S-glutathionylation as a regulatory mechanism to control cell death. Antioxid. Redox Signal. 2012, 16:496-505.
48. Lee C.G., Cho S.J., Kang M.J., Chapoval S.P., Lee P.J., Noble P.W., Yehualaeshet T., Lu B., Flavell R.A., Milbrandt J., Homer R.J., Elias J.A. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J. Exp. Med. 2004, 200:377-389.
49. Budinger G.R., Mutlu G.M., Eisenbart J., Fuller A.C., Bellmeyer A.A., Baker C.M., Wilson M., Ridge K., Barrett T.A., Lee V.Y., Chandel N.S. Proapoptotic Bid is required for pulmonary fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:4604-4609.
50. Anathy V., Roberson E., Cunniff B., Nolin J.D., Hoffman S., Spiess P., Guala A.S., Lahue K.G., Goldman D., Flemer S., van der Vliet A., Heintz N.H., Budd R.C., Tew K.D., Janssen-Heininger Y.M. Oxidative processing of latent fas in the endoplasmic reticulum controls the strength of apoptosis. Mol. Cell. Biol. 2012, 32:3464-3478.
51. Horan G.S., Wood S., Ona V., Li D.J., Lukashev M.E., Weinreb P.H., Simon K.J., Hahm K., Allaire N.E., Rinaldi N.J., Goyal J., Feghali-Bostwick C.A., Matteson E.L., O'Hara C., Lafyatis R., Davis G.S., Huang X., Sheppard D., Violette S.M. Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am. J. Respir. Crit. Care Med. 2008, 177:56-65.
52. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutat. Res. 2012, 730:52-58.
53. Alder J.K., Chen J.J., Lancaster L., Danoff S., Su S.C., Cogan J.D., Vulto I., Xie M., Qi X., Tuder R.M., Phillips J.A., Lansdorp P.M., Loyd J.E., Armanios M.Y. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13051-13056.
54. Passos J.F., Saretzki G., Ahmed S., Nelson G., Richter T., Peters H., Wappler I., Birket M.J., Harold G., Schaeuble K., Birch-Machin M.A., Kirkwood T.B., von Zglinicki T. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 2007, 5:e110.
55. Degryse A.L., Xu X.C., Newman J.L., Mitchell D.B., Tanjore H., Polosukhin V.V., Jones B.R., McMahon F.B., Gleaves L.A., Phillips J.A., Cogan J.D., Blackwell T.S., Lawson W.E. Telomerase deficiency does not alter bleomycin-induced fibrosis in mice. Exp. Lung Res. 2012, 38:124-134.
56. Seibold M.A., Wise A.L., Speer M.C., Steele M.P., Brown K.K., Loyd J.E., Fingerlin T.E., Zhang W., Gudmundsson G., Groshong S.D., Evans C.M., Garantziotis S., Adler K.B., Dickey B.F., du Bois R.M., Yang I.V., Herron A., Kervitsky D., Talbert J.L., Markin C., Park J., Crews A.L., Slifer S.H., Auerbach S., Roy M.G., Lin J., Hennessy C.E., Schwarz M.I., Schwartz D.A. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011, 364:1503-1512.
57. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., Gottlieb E., Green D.R., Hengartner M.O., Kepp O., Knight R.A., Kumar S., Lipton S.A., Lu X., Madeo F., Malorni W., Mehlen P., Nunez G., Peter M.E., Piacentini M., Rubinsztein D.C., Shi Y., Simon H.U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012, 19:107-120.
58. Malhotra J.D., Kaufman R.J. ER stress and its functional link to mitochondria: role in cell survival and death. Cold Spring Harb. Perspect. Biol. 2011, 3. 10.1101/cshperspecta004424.
59. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
60. Panduri V., Weitzman S.A., Chandel N., Kamp D.W. The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis. Am. J. Respir. Cell Mol. Biol. 2003, 28:241-248.
61. Panduri V., Liu G., Surapureddi S., Kondapalli J., Soberanes S., de Souza-Pinto N.C., Bohr V.A., Budinger G.R., Schumacker P.T., Weitzman S.A., Kamp D.W. Role of mitochondrial hOGG1 and aconitase in oxidant-induced lung epithelial cell apoptosis. Free Radic. Biol. Med. 2009, 47:750-759.
62. Panduri V., Weitzman S.A., Chandel N.S., Kamp D.W. Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L1220-L1227.
63. Panduri V., Surapureddi S., Soberanes S., Weitzman S.A., Chandel N., Kamp D.W. P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis. Am. J. Respir. Cell Mol. Biol. 2006, 34:443-452.
64. Lounsbury K.M., Stern M., Taatjes D., Jaken S., Mossman B.T. Increased localization and substrate activation of protein kinase C delta in lung epithelial cells following exposure to asbestos. Am. J. Pathol. 2002, 160:1991-2000.
65. Buder-Hoffmann S.A., Shukla A., Barrett T.F., MacPherson M.B., Lounsbury K.M., Mossman B.T. A protein kinase Cdelta-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestos. Am. J. Pathol. 2009, 174:449-459.
66. Lawson W.E., Crossno P.F., Polosukhin V.V., Roldan J., Cheng D.S., Lane K.B., Blackwell T.R., Xu C., Markin C., Ware L.B., Miller G.G., Loyd J.E., Blackwell T.S. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L1119-L1126.
67. Korfei M., Ruppert C., Mahavadi P., Henneke I., Markart P., Koch M., Lang G., Fink L., Bohle R.M., Seeger W., Weaver T.E., Guenther A. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008, 178:838-846.
68. Tanjore H., Blackwell T.S., Lawson W.E. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 302:L721-L729.
69. de Brito O.M., Scorrano L. An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. EMBO J. 2010, 29:2715-2723.
70. Meunier J., Hayashi T. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB. J. Pharmacol. Exp. Ther. 2010, 332:388-397.
71. Klee M., Pallauf K., Alcala S., Fleischer A., Pimentel-Muinos F.X. Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak. EMBO J. 2009, 1757-1768.
72. Zhong Q., Zhou B., Ann D.K., Minoo P., Liu Y., Banfalvi A., Krishnaveni M.S., Dubourd M., Demaio L., Willis B.C., Kim K.J., duBois R.M., Crandall E.D., Beers M.F., Borok Z. Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. Am. J. Respir. Cell Mol. Biol. 2011, 45:498-509.
73. Maguire J.A., Mulugeta S., Beers M.F. Multiple ways to die: delineation of the unfolded protein response and apoptosis induced by surfactant protein C BRICHOS mutants. Int. J. Biochem. Cell Biol. 2012, 44:101-112.
74. Lawson W.E., Cheng D.S., Degryse A.L., Tanjore H., Polosukhin V.V., Xu X.C., Newcomb D.C., Jones B.R., Roldan J., Lane K.B., Morrisey E.E., Beers M.F., Yull F.E., Blackwell T.S. Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:10562-10567.
75. Baek H.A., Kim do S., Park H.S., Jang K.Y., Kang M.J., Lee D.G., Moon W.S., Chae H.J., Chung M.J. Involvement of endoplasmic reticulum stress in myofibroblastic differentiation of lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 2012, 46:731-739.
76. Torres-Gonzalez E., Bueno M., Tanaka A., Krug L.T., Cheng D.S., Polosukhin V.V., Sorescu D., Lawson W.E., Blackwell T.S., Rojas M., Mora A.L. Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis. Am. J. Respir. Cell Mol. Biol. 2012, 46:748-756.
77. Liu G., Beri R., Mueller A., Kamp D.W. Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. Chem. Biol. Interact. 2010, 188:309-318.
78. Harper J.W., Elledge S.J. The DNA damage response: ten years after. Mol. Cell 2007, 28:739-745.
79. Janicke R.U., Sohn D., Schulze-Osthoff K. The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death Differ. 2008, 15:959-976.
80. Chipuk J.E., Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006, 13:994-1002.
81. Achanta G., Huang P. Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 2004, 64:6233-6239.
82. Brady C.A., Jiang D., Mello S.S., Johnson T.M., Jarvis L.A., Kozak M.M., Kenzelmann Broz D., Basak S., Park E.J., McLaughlin M.E., Karnezis A.N., Attardi L.D. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 2011, 145:571-583.
83. Kenzelmann Broz D., Attardi L.D. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models. Carcinogenesis 2010, 31:1311-1318.
84. Bakhanashvili M., Grinberg S., Bonda E., Simon A.J., Moshitch-Moshkovitz S., Rahav G. p53 in mitochondria enhances the accuracy of DNA synthesis. Cell Death Differ. 2008, 15:1865-1874.
85. Lebedeva M.A., Eaton J.S., Shadel G.S. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim. Biophys. Acta 2009, 1787:328-334.
86. Nelson A., Mendoza T., Hoyle G.W., Brody A.R., Fermin C., Morris G.F. Enhancement of fibrogenesis by the p53 tumor suppressor protein in asbestos-exposed rodents. Chest 2001, 120:33S-34S.
87. Burmeister B., Schwerdtle T., Poser I., Hoffmann E., Hartwig A., Muller W.U., Rettenmeier A.W., Seemayer N.H., Dopp E. Effects of asbestos on initiation of DNA damage, induction of DNA-strand breaks, P53-expression and apoptosis in primary, SV40-transformed and malignant human mesothelial cells. Mutat. Res. 2004, 558:81-92.
88. Plataki M., Koutsopoulos A.V., Darivianaki K., Delides G., Siafakas N.M., Bouros D. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005, 127:266-274.
89. Mishra A., Liu J.Y., Brody A.R., Morris G.F. Inhaled asbestos fibers induce p53 expression in the rat lung. Am. J. Respir. Cell Mol. Biol. 1997, 16:479-485.
90. Johnson N.F., Jaramillo R.J. p53, Cip1, and Gadd153 expression following treatment of A549 cells with natural and man-made vitreous fibers. Environ. Health Perspect. 1997, 105(Suppl. 5):1143-1145.
91. Matsuoka M., Igisu H., Morimoto Y. Phosphorylation of p53 protein in A549 human pulmonary epithelial cells exposed to asbestos fibers. Environ. Health Perspect. 2003, 111:509-512.
92. Kopnin P.B., Kravchenko I.V., Furalyov V.A., Pylev L.N., Kopnin B.P. Cell type-specific effects of asbestos on intracellular ROS levels, DNA oxidation and G1 cell cycle checkpoint. Oncogene 2004, 23:8834-8840.
93. Nuorva K., Makitaro R., Huhti E., Kamel D., Vahakangas K., Bloigu R., Soini Y., Paakko P. p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke. Am. J. Respir. Crit. Care Med. 1994, 150:528-533.
94. Husgafvel-Pursiainen K., Kannio A., Oksa P., Suitiala T., Koskinen H., Partanen R., Hemminki K., Smith S., Rosenstock-Leibu R., Brandt-Rauf P.W. Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure. Environ. Mol. Mutagen. 1997, 30:224-230.
95. Lin F., Liu Y., Keshava N., Li S. Crocidolite induces cell transformation and p53 gene mutation in BALB/c-3T3 cells. Teratog. Carcinog. Mutagen. 2000, 20:273-281.
96. Yee H., Yie T.A., Goldberg J., Wong K.M., Rom W.N. Immunohistochemical study of fibrosis and adenocarcinoma in dominant-negative p53 transgenic mice exposed to chrysotile asbestos and benzo(a)pyrene. J. Environ. Pathol. Toxicol. Oncol. 2008, 27:267-276.
97. Nymark P., Lindholm P.M., Korpela M.V., Lahti L., Ruosaari S., Kaski S., Hollmen J., Anttila S., Kinnula V.L., Knuutila S. Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines. BMC Genomics 2007, 8:62.
98. Hevel J.M., Olson-Buelow L.C., Ganesan B., Stevens J.R., Hardman J.P., Aust A.E. Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions. BMC Genomics 2008, 9:376.
99. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 2003, 15:247-254.
100. Wu G.S. The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol. Ther. 2004, 3:156-161.
101. Michalak E., Villunger A., Erlacher M., Strasser A. Death squads enlisted by the tumour suppressor p53. Biochem. Biophys. Res. Commun. 2005, 331:786-798.
102. Shukla A., Gulumian M., Hei T.K., Kamp D., Rahman Q., Mossman B.T. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic. Biol. Med. 2003, 34:1117-1129.
103. Lane D.P. Cancer. p53, guardian of the genome. Nature 1992, 358:15-16.
104. Brooks C.L., Gu W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 2006, 21:307-315.
105. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
106. Aylon Y., Oren M. Living with p53, dying of p53. Cell 2007, 130:597-600.
107. Olsson A., Manzl C., Strasser A., Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?. Cell Death Differ. 2007, 14:1561-1575.
108. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
109. Tomita Y., Marchenko N., Erster S., Nemajerova A., Dehner A., Klein C., Pan H., Kessler H., Pancoska P., Moll U.M. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem. 2006, 281:8600-8606.
110. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., Yodoi J. Redox control of cell death. Antioxid. Redox Signal. 2002, 4:405-414.
111. Essmann F., Pohlmann S., Gillissen B., Daniel P.T., Schulze-Osthoff K., Janicke R.U. Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis. J. Biol. Chem. 2005, 280:37169-37177.
112. Sengupta S., Harris C.C. p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 2005, 6:44-55.
113. Roos W.P., Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 2006, 12:440-450.
114. Gredilla R., Bohr V.A., Stevnsner T. Mitochondrial DNA repair and association with aging - an update. Exp. Gerontol. 2010, 45:478-488.
115. Ralph S.J., Rodriguez-Enriquez S., Neuzil J., Saavedra E., Moreno-Sanchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Mol. Aspects Med. 2010, 31:145-170.
116. Gredilla R., Garm C., Holm R., Bohr V.A., Stevnsner T. Differential age-related changes in mitochondrial DNA repair activities in mouse brain regions. Neurobiol. Aging 2010, 31:993-1002.
117. Muller F.L., Liu Y., Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 2004, 279:49064-49073.
118. Weinberg F., Hamanaka R., Wheaton W.W., Weinberg S., Joseph J., Lopez M., Kalyanaraman B., Mutlu G.M., Budinger G.R., Chandel N.S. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8788-8793.
119. Kamp D.W., Shacter E., Weitzman S.A. Chronic inflammation and cancer: the role of the mitochondria. Oncology (Williston Park) 2011, 25:400-410.
120. Bohr V.A. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic. Biol. Med. 2002, 32:804-812.
121. Mirbahai L., Kershaw R.M., Green R.M., Hayden R.E., Meldrum R.A., Hodges N.J. Use of a molecular beacon to track the activity of base excision repair protein OGG1 in live cells. DNA Repair 2010, 9:144-152.
122. Bohr V.A., Stevnsner T., de Souza-Pinto N.C. Mitochondrial DNA repair of oxidative damage in mammalian cells. Gene 2002, 286:127-134.
123. Dobson A.W., Xu Y., Kelley M.R., LeDoux S.P., Wilson G.L. Enhanced mitochondrial DNA repair and cellular survival after oxidative stress by targeting the human 8-oxoguanine glycosylase repair enzyme to mitochondria. J. Biol. Chem. 2000, 275:37518-37523.
124. Ruchko M., Gorodnya O., LeDoux S.P., Alexeyev M.F., Al-Mehdi A.B., Gillespie M.N. Mitochondrial DNA damage triggers mitochondrial dysfunction and apoptosis in oxidant-challenged lung endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L530-L535.
125. Rachek L.I., Grishko V.I., Ledoux S.P., Wilson G.L. Role of nitric oxide-induced mtDNA damage in mitochondrial dysfunction and apoptosis. Free Radic. Biol. Med. 2006, 40:754-762.
126. Harrison J.F., Rinne M.L., Kelley M.R., Druzhyna N.M., Wilson G.L., Ledoux S.P. Altering DNA base excision repair: use of nuclear and mitochondrial-targeted N-methylpurine DNA glycosylase to sensitize astroglia to chemotherapeutic agents. Glia 2007, 55:1416-1425.
127. Ruchko M.V., Gorodnya O.M., Zuleta A., Pastukh V.M., Gillespie M.N. The DNA glycosylase Ogg1 defends against oxidant-induced mtDNA damage and apoptosis in pulmonary artery endothelial cells. Free Radic. Biol. Med. 2011, 50:1107-1113.
128. Chouteau J.M., Obiako B., Gorodnya O.M., Pastukh V.M., Ruchko M.V., Wright A.J., Wilson G.L., Gillespie M.N. Mitochondrial DNA integrity may be a determinant of endothelial barrier properties in oxidant-challenged rat lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L892-L898.
129. Shukla A., Jung M., Stern M., Fukagawa N.K., Taatjes D.J., Sawyer D., Van Houten B., Mossman B.T. Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1018-L1025.
130. Nishioka K., Ohtsubo T., Oda H., Fujiwara T., Kang D., Sugimachi K., Nakabeppu Y. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol. Biol. Cell 1999, 10:1637-1652.
131. Takao M., Aburatani H., Kobayashi K., Yasui A. Mitochondrial targeting of human DNA glycosylases for repair of oxidative DNA damage. Nucleic Acids Res. 1998, 26:2917-2922.
132. Hashiguchi K., Stuart J.A., de Souza-Pinto N.C., Bohr V.A. The C-terminal alphaO helix of human Ogg1 is essential for 8-oxoguanine DNA glycosylase activity: the mitochondrial beta-Ogg1 lacks this domain and does not have glycosylase activity. Nucleic Acids Res. 2004, 32:5596-5608.
133. Gardner P.R., Nguyen D.D., White C.W. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:12248-12252.
134. Yan L.J., Levine R.L., Sohal R.S. Oxidative damage during aging targets mitochondrial aconitase. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:11168-11172.
135. Cantu D., Fulton R.E., Drechsel D.A., Patel M. Mitochondrial aconitase knockdown attenuates paraquat-induced dopaminergic cell death via decreased cellular metabolism and release of iron and H(2)O(2). J. Neurochem. 2011, 118:79-92.
136. Singh K.K., Desouki M.M., Franklin R.B., Costello L.C. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol. Cancer 2006, 5:14.
137. Williams M.D., Van Remmen H., Conrad C.C., Huang T.T., Epstein C.J., Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 1998, 273:28510-28515.
138. Park L.C., Albers D.S., Xu H., Lindsay J.G., Beal M.F., Gibson G.E. Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy. J. Neurosci. Res. 2001, 66:1028-1034.
139. Bradley J.L., Blake J.C., Chamberlain S., Thomas P.K., Cooper J.M., Schapira A.H. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum. Mol. Genet. 2000, 9:275-282.
140. Tabrizi S.J., Cleeter M.W., Xuereb J., Taanman J.W., Cooper J.M., Schapira A.H. Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol. 1999, 45:25-32.
141. Chen X.J., Wang X., Kaufman B.A., Butow R.A. Aconitase couples metabolic regulation to mitochondrial DNA maintenance. Science 2005, 307:714-717.
142. Youn C.K., Song P.I., Kim M.H., Kim J.S., Hyun J.W., Choi S.J., Yoon S.P., Chung M.H., Chang I.Y., You H.J. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts. Mol. Cancer Res. 2007, 5:1083-1098.
143. Bacsi A., Chodaczek G., Hazra T.K., Konkel D., Boldogh I. Increased ROS generation in subsets of OGG1 knockout fibroblast cells. Mech. Ageing Dev. 2007, 128:637-649.
144. Xie Y., Yang H., Miller J.H., Shih D.M., Hicks G.G., Xie J., Shiu R.P. Cells deficient in oxidative DNA damage repair genes Myh and Ogg1 are sensitive to oxidants with increased G2/M arrest and multinucleation. Carcinogenesis 2008, 29:722-728.
145. Bota D.A., Davies K.J. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat. Cell Biol. 2002, 4:674-680.
146. Bulteau A.L., O'Neill H.A., Kennedy M.C., Ikeda-Saito M., Isaya G., Szweda L.I. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 2004, 305:242-245.
147. Roepke M., Diestel A., Bajbouj K., Walluscheck D., Schonfeld P., Roessner A., Schneider-Stock R., Gali-Muhtasib H. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol. Ther. 2007, 6:160-169.
148. Tsui K.H., Feng T.H., Lin Y.F., Chang P.L., Juang H.H. p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. Prostate 2011, 71:62-70.
149. Pociask D.A., Sime P.J., Brody A.R. Asbestos-derived reactive oxygen species activate TGF-beta1. Lab. Invest. 2004, 84:1013-1023.
150. Jobling M.F., Mott J.D., Finnegan M.T., Jurukovski V., Erickson A.C., Walian P.J., Taylor S.E., Ledbetter S., Lawrence C.M., Rifkin D.B., Barcellos-Hoff M.H. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat. Res. 2006, 166:839-848.
151. Gorowiec M.R., Borthwick L.A., Parker S.M., Kirby J.A., Saretzki G.C., Fisher A.J. Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-beta1-dependent mechanism. Free Radic. Biol. Med. 2012, 52:1024-1032.
152. Cui Y., Robertson J., Maharaj S., Waldhauser L., Niu J., Wang J., Farkas L., Kolb M., Gauldie J. Oxidative stress contributes to the induction and persistence of TGF-beta1 induced pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2011, 43:1122-1133.
153. Kayanoki Y., Fujii J., Suzuki K., Kawata S., Matsuzawa Y., Taniguchi N. Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes. J. Biol. Chem. 1994, 269:15488-15492.
154. Yoon Y.S., Lee J.H., Hwang S.C., Choi K.S., Yoon G. TGF-beta1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene 2005, 24:1895-1903.
155. Herrera B., Alvarez A.M., Sanchez A., Fernandez M., Roncero C., Benito M., Fabregat I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J. 2001, 15:741-751.
156. Albright C.D., Salganik R.I., Craciunescu C.N., Mar M.H., Zeisel S.H. Mitochondrial and microsomal derived reactive oxygen species mediate apoptosis induced by transforming growth factor-beta1 in immortalized rat hepatocytes. J. Cell. Biochem. 2003, 89:254-261.
157. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
158. Carmona-Cuenca I., Roncero C., Sancho P., Caja L., Fausto N., Fernandez M., Fabregat I. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J. Hepatol. 2008, 49:965-976.
159. Sancho P., Bertran E., Caja L., Carmona-Cuenca I., Murillo M.M., Fabregat I. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. Biochim. Biophys. Acta 2009, 1793:253-263.
160. Willis B.C., Liebler J.M., Luby-Phelps K., Nicholson A.G., Crandall E.D., du Bois R.M., Borok Z. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 2005, 166:1321-1332.
161. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., Leake D., Godden E.L., Albertson D.G., Nieto M.A., Werb Z., Bissell M.J. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127.
162. Zhang A., Jia Z., Guo X., Yang T. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am. J. Physiol. Ren. Physiol. 2007, 293:F723-F731.
163. Yao H.W., Xie Q.M., Chen J.Q., Deng Y.M., Tang H.F. TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro. Life Sci. 2004, 76:29-37.
164. Kasai H., Allen J.T., Mason R.M., Kamimura T., Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 2005, 6:56.
165. Margetts P.J., Bonniaud P., Liu L., Hoff C.M., Holmes C.J., West-Mays J.A., Kelly M.M. Transient overexpression of TGF-β1 induces epithelial mesenchymal transition in the rodent peritoneum. J. Am. Soc. Nephrol. 2005, 16:425-436.
166. Kim K.K., Kugler M.C., Wolters P.J., Robillard L., Galvez M.G., Brumwell A.N., Sheppard D., Chapman H.A. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13180-13185.
167. Rhyu D.Y., Yang Y., Ha H., Lee G.T., Song J.S., Uh S.T., Lee H.B. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol. 2005, 16:667-675.
168. Zhou B., Liu Y., Kahn M., Ann D.K., Han A., Wang H., Nguyen C., Flodby P., Zhong Q., Krishnaveni M.S., Liebler J.M., Minoo P., Crandall E.D., Borok Z. Interactions between beta-catenin and transforming growth factor-beta signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J. Biol. Chem. 2012, 287:7026-7038.
169. Zhang D.Y., Wang H.J., Tan Y.Z. Wnt/beta-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway. PLoS One 2011, 6:e21397.
170. Wen J.W., Hwang J.T., Kelly G.M. Reactive oxygen species and Wnt signalling crosstalk patterns mouse extraembryonic endoderm. Cell. Signal. 2012, 24:2337-2348.